Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Granada
Clinical trial register · Spain

Clinical Trials in Granada, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Spain and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5875 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:18 UTC
5875
Studies in scope
all four open statuses
3096
Recruiting now
open to new participants
1137
Lead sponsors
across recruiting studies
Top sites
Barcelona 111 Madrid 100 Valencia 42 Santiago Compostela 30 Seville 30
Narrow the registerReset
Recruitment status
Phase
Target enrolment
to

Trials with a site in Granada

15 of 5875 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Spain
Start
Recruiting
A Phase Ib/II Open-label Study of AMO959 With Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI in Adult Participants With PSMA-positive mCRPC
NCT07226986PSMA-positive Metastatic Castration Resistant Prostate Cancer (mCRPC) With Prior Exposure to One Prior ARPI Who Are Candidates for Taxane-based Chemotherapy
Novartis Pharmaceuticals
Phase 1/2
123
Granada, L'Hospitalet de Llobregat, Barcelona, Madrid
2025-12-05
Active, closed
Novartis Pharmaceuticals
Phase 2
138
Granada, El Palmar, Barcelona, Seville
2025-07-03
Active, closed
Novartis Pharmaceuticals
Observational
219
Cadiz, Granada, Huelva, Jaén, Marbella, Mallorca, Puerto Real, Santander
2025-06-16
Recruiting
Novartis Pharmaceuticals
Phase 2
224
Badalona, Alicante, Granada, Las Palmas GC, Madrid, Pontevedra
2025-05-16
Active, closed
Novartis Pharmaceuticals
Phase 3
565
Granada, Palma, Barcelona, Granollers, Las Palmas GC, Madrid, Pontevedra, Seville
2025-03-20
Active, closed
Novartis Pharmaceuticals
Phase 1
42
Granada, Badalona, L'Hospitalet de Llobregat, Madrid
2024-05-15
Active, closed
Novartis Pharmaceuticals
Phase 2
23
Granada, El Palmar
2024-04-04
Recruiting
Novartis Pharmaceuticals
Phase 3
450
Granada, L'Hospitalet de Llobregat, Barcelona, El Palmar, Madrid, Seville, Valencia
2024-03-12
Active, closed
Novartis Pharmaceuticals
Phase 3
362
Santiago, Granada, Barcelona, Alicante, Madrid, Valencia
2023-12-07
Active, closed
Novartis Pharmaceuticals
Phase 3
470
Granada, Barcelona, Córdoba, Las Palmas GC, Valencia
2023-11-15
Active, closed
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
NCT05739383Primary Prevention of Atherosclerotic Cardiovascular Disease
Novartis Pharmaceuticals
Phase 3
14,012
Ferrol, Santiago, Santiago Compostela, Elche, Granada, Huelva, Marbella, Málaga
2023-03-09
Active, closed
A Study of Oral Asciminib Versus Other TKIs in Adult Patients With Newly Diagnosed Ph+ CML-CP
NCT04971226Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive
Novartis Pharmaceuticals
Phase 3
405
Granada, El Palmar, Pamplona, Barcelona, Madrid
2021-10-06
Active, closed
Novartis Pharmaceuticals
Phase 2
248
Granada, Sabadell, Manises, Barcelona, Las Palmas GC, Valencia
2019-02-27
Active, closed
Novartis Pharmaceuticals
Phase 3
5,101
Elche, Granada, Huelva, Jaén, Vitoria-Gasteiz, Badalona, L'Hospitalet de Llobregat, Manresa
2018-12-07
Rows per page Showing 1–15 of 15
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Spanish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 October 2026. https://priyalifescience.com/clinical-trials-spain/city/granada

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Spain and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,875 studies in total at the last sync on 11 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 15 of those studies with a site in Granada that also match the filters currently applied.

How many clinical trials are recruiting in Granada?

3 of the 15 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 12 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Granada), 15 studies
PhaseStudiesRecruitingShare
Phase 37146.7%
Phase 24126.7%
Phase 12013.3%
Observational106.7%
Phase 1/2116.7%

Most active sponsors

Lead sponsors with the most studies (Granada)
Lead sponsorStudiesRecruiting
Novartis Pharmaceuticals153
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.